LLY

726.08

-2.8%↓

JNJ

153.46

-0.08%↓

ABBV

181.73

-1.73%↓

NVO

68.16

+0.29%↑

UNH

303.18

-5.79%↓

LLY

726.08

-2.8%↓

JNJ

153.46

-0.08%↓

ABBV

181.73

-1.73%↓

NVO

68.16

+0.29%↑

UNH

303.18

-5.79%↓

LLY

726.08

-2.8%↓

JNJ

153.46

-0.08%↓

ABBV

181.73

-1.73%↓

NVO

68.16

+0.29%↑

UNH

303.18

-5.79%↓

LLY

726.08

-2.8%↓

JNJ

153.46

-0.08%↓

ABBV

181.73

-1.73%↓

NVO

68.16

+0.29%↑

UNH

303.18

-5.79%↓

LLY

726.08

-2.8%↓

JNJ

153.46

-0.08%↓

ABBV

181.73

-1.73%↓

NVO

68.16

+0.29%↑

UNH

303.18

-5.79%↓

Search

Microbot Medical Inc

Atidarymo kaina

2.53 -3.07

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

2.51

Max

2.64

Pagrindiniai rodikliai

By Trading Economics

Pajamos

791K

-2.6M

Pelnas, tenkantis vienai akcijai

-0.08

Darbuotojai

20

EBITDA

-127K

-3.4M

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

+243.51% upside

Dividendai

By Dow Jones

Kitas uždarbis

2025-08-12

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

7.2M

100M

Ankstesnė atidarymo kaina

5.6

Ankstesnė uždarymo kaina

2.53

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Neutral Evidence

Microbot Medical Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-05-20 20:54; UTC

Įsigijimai, susijungimai, perėmimai

PNC to Buy Private-Equity Agent Aqueduct Capital

2025-05-20 20:50; UTC

Uždarbis

Palo Alto Networks Posts Higher 3Q Sales, Profit Slips

2025-05-20 23:48; UTC

Įsigijimai, susijungimai, perėmimai

Kraft Heinz Evaluating Strategic Transactions, Berkshire Hathaway Steps Away From Board -- Update

2025-05-20 23:42; UTC

Rinkos pokalbiai

Nikkei May Trade Rangebound Amid Tariff Uncertainty -- Market Talk

2025-05-20 23:39; UTC

Rinkos pokalbiai

Gold Steady, Supported by Lingering U.S. Fiscal-Deficit Concerns -- Market Talk

2025-05-20 23:08; UTC

Rinkos pokalbiai

James Hardie's Repair & Remodel Outlook Surprises RBC -- Market Talk

2025-05-20 22:46; UTC

Įsigijimai, susijungimai, perėmimai

Gold Road: Takeover Remains Subject to Independent Expert Findings; Shareholder, Court Approval

2025-05-20 22:45; UTC

Įsigijimai, susijungimai, perėmimai

Gold Road: Notified Australia Government Has No Objections to Takeover by Gold Fields

2025-05-20 22:44; UTC

Svarbiausios naujienos

Venezuela Frees U.S. Air Force Veteran in Overture to Trump -- 2nd Update

2025-05-20 22:20; UTC

Svarbiausios naujienos

In Latest EV Pullback, Ford to Share Battery Plant With Nissan -- WSJ

2025-05-20 22:00; UTC

Uždarbis

ZTO Express (Cayman) 1Q Adj EPS 37c >ZTO

2025-05-20 22:00; UTC

Uždarbis

ZTO Express (Cayman) 1Q EPS 34c >ZTO

2025-05-20 22:00; UTC

Uždarbis

ZTO Express (Cayman) 1Q Rev $1.5B >ZTO

2025-05-20 21:44; UTC

Uždarbis

James Hardie Industries 4Q Adj EPS 36c >JHX

2025-05-20 21:44; UTC

Uždarbis

James Hardie Industries: Sees FY26 North America Net Sales Growth Up Low Single Digits >JHX

2025-05-20 21:44; UTC

Uždarbis

James Hardie Industries 4Q EPS 10c >JHX

2025-05-20 21:44; UTC

Uždarbis

James Hardie Industries 4Q Sales $972M >JHX

2025-05-20 20:52; UTC

Svarbiausios naujienos

Elon Musk to Cut Back Political Spending -- 3rd Update

2025-05-20 20:52; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2025-05-20 20:52; UTC

Rinkos pokalbiai

Mexican Stocks Near Record High As Trade Concerns Ease -- Market Talk

2025-05-20 20:30; UTC

Įsigijimai, susijungimai, perėmimai

PNC Financial: Aqueduct Acquisition Expected to Close in Mid-Summer, Terms Won't be Disclosed >PNC

2025-05-20 20:28; UTC

Įsigijimai, susijungimai, perėmimai

PNC Bank Agrees To Acquire Aqueduct Capital Group To Complement Harris Williams Capabilities >PNC

2025-05-20 20:23; UTC

Įsigijimai, susijungimai, perėmimai

Tesla CEO Musk Says He Plans to Be at White House for a Couple Days Every Few Weeks

2025-05-20 20:22; UTC

Uždarbis

XP 1Q Adj EPS BRL2.29 >XP

2025-05-20 20:22; UTC

Uždarbis

XP 1Q Rev BRL4.345B >XP

2025-05-20 20:21; UTC

Įsigijimai, susijungimai, perėmimai

Tesla CEO Musk: 'We're in the Big Bang of Intelligence Explosion'

2025-05-20 20:20; UTC

Svarbiausios naujienos

Fed's Bostic Signals Longer Delay in Cutting Interest Rates -- Barrons.com

2025-05-20 20:19; UTC

Įsigijimai, susijungimai, perėmimai

Tesla CEO Musk Says He Doesn't Currently Have Plans to Merge Tesla, xAI

2025-05-20 20:11; UTC

Svarbiausios naujienos

Venezuela Frees U.S. Air Force Veteran in Overture to Trump -- Update

2025-05-20 20:09; UTC

Uždarbis

Palo Alto Networks 3Q Remaining Performance Obligation $13.5 B >PANW

Akcijų palyginimas

Kainos pokytis

Microbot Medical Inc Prognozė

Kainos tikslas

By TipRanks

243.51% į viršų

12 mėnesių prognozė

Vidutinis 9 USD  243.51%

Aukščiausias 9 USD

Žemiausias 9 USD

Remiantis 1 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Microbot Medical Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

1 ratings

1

Pirkti

0

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

2.52 / 2.57Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Neutral Evidence

Vidutinės trukmės periodas

Very Strong Bullish Evidence

Ilgalaikis periodas

Weak Bullish Evidence

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Microbot Medical Inc

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development; and Phase 2 collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.